David J Moss - 21 Mar 2022 Form 4 Insider Report for Inmune Bio, Inc. (INMB)

Role
CFO, Treasurer & Secretary, 10%+ Owner
Signature
/s/ David Moss
Issuer symbol
INMB
Transactions as of
21 Mar 2022
Net transactions value
+$149,995
Form type
4
Filing time
23 Mar 2022, 16:30:43 UTC
Previous filing
04 Nov 2021
Next filing
31 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INMB Common Stock Award $149,995 +17,793 +1.5% $8.43 1,236,951 22 Mar 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INMB Option (right to buy) Award $0 +130,000 $0.000000 130,000 21 Mar 2022 Common Stock 130,000 $7.92 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchase price of the common stock being reported is the closing price per share immediately preceding the entering into of the binding agreement to issue the securities . These shares were purchased by the Reporting Person directly from Issuer.
F2 Granted pursuant to the 2021 Stock Incentive Plan. One third (1/3) of the Option will vest at the one-year anniversary of the grant date and the remaining unvested Option will become vested and exercisable 1/24th every month thereafter until the Option is 100% vested which shall occur on the three-year anniversary of the grant date.